Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data. | World J Gastrointest Oncol | 2022 | 36187396 | PubTator, text mining | PubMed |
| Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma. | Front Immunol | 2022 | 36177001 | PubTator, text mining | PubMed |
| Proteomics Combined with RNA Sequencing to Screen Biomarkers of Sepsis. | Infect Drug Resist | 2022 | 36172619 | PubTator, text mining | PubMed |
| The complement system and autoimmune diseases. | Chronic Dis Transl Med | 2022 | 36161202 | PubTator, text mining | PubMed |
| Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids. | J Neurochem | 2022 | 36156258 | PubTator, text mining | PubMed |
| Algorithms for the executable programs planning on supercomputers. | PLoS One | 2022 | 36155542 | PubTator, text mining | PubMed |
| Effect of Platelet-Rich Plasma Augmentation on Endoscopy-Assisted Percutaneous Achilles Tendon Repair. | J Clin Med | 2022 | 36143034 | PubTator, text mining | PubMed |
| Impact of Freeze-Drying on Cord Blood (CB), Serum (S), and Platelet-Rich Plasma (CB-PRP) Preparations on Growth Factor Content and In Vitro Cell Wound Healing. | Int J Mol Sci | 2022 | 36142617 | PubTator, text mining | PubMed |
| Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection. | Int J Mol Sci | 2022 | 36142503 | PubTator, text mining | PubMed |
| An Integrated Analysis of Lactation-Related miRNA and mRNA Expression Profiles in Donkey Mammary Glands. | Genes (Basel) | 2022 | 36140805 | PubTator, text mining | PubMed |
| An Update on In Vitro Folliculogenesis: A New Technique for Post-Cancer Fertility. | Biomedicines | 2022 | 36140316 | PubTator, text mining | PubMed |
| Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors. | Nat Commun | 2022 | 36127336 | PubTator, text mining | PubMed |
| COVID-19: A Rare Cause of Hemolytic Uremic Syndrome. | Cureus | 2022 | 36120203 | PubTator, text mining | PubMed |
| An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae. | Front Immunol | 2022 | 36110842 | PubTator, text mining | PubMed |
| Assessment of Knowledge, Awareness, and Perception of Platelet-Rich Plasma among Oral Surgeons. | J Pharm Bioallied Sci | 2022 | 36110738 | PubTator, text mining | PubMed |
| Platelet-rich plasma treatment in patients with refractory thin endometrium and recurrent implantation failure: A comprehensive review. | Clin Exp Reprod Med | 2022 | 36097732 | PubTator, text mining | PubMed |
| Autologous Protein Solution processing alters lymphoid and myeloid cell populations and modulates gene expression dependent on cell type. | Arthritis Res Ther | 2022 | 36096945 | PubTator, text mining | PubMed |
| Deceiving and escaping complement - the evasive journey of the malaria parasite. | Trends Parasitol | 2022 | 36089499 | PubTator, text mining | PubMed |
| Platelet Rich Plasma in the Repair of Articular Cartilage Injury: A Narrative Review. | Cartilage | 2022 | 36086807 | PubTator, text mining | PubMed |
| Exosome Proteomics Reveals the Deregulation of Coagulation, Complement and Lipid Metabolism Proteins in Gestational Diabetes Mellitus. | Molecules | 2022 | 36080270 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=26